MEDICINAL CANNABIS MARKET ANALYSIS

Medicinal Cannabis Market, By Product Type (Flower, Concentrates, Edibles, Topicals & Transdermals, and Others ), By Compound (Tetrahydrocannabinol (THC) and Cannabidiol (CBD)), By Application (Cancer, Arthritis, Chronic Pain, Parkinson’s Disease, Epilepsy, and Others), By Distribution Channel (Hospital Pharmacies , Retail Pharmacies , Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Mar 2024
Code : CMI40
Pages :171
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges: Stringent regulations

The medicinal cannabis market currently faces several challenges. As the legal status and regulations surrounding cannabis use varies greatly around the world, entering new international markets can be difficult to navigate differing laws. Additionally, further clinical research is still needed to gain widespread medical acceptance and insurance coverage. There is also limited standardized cultivation practices and a shortage of large-scale, low-cost producers which keeps prices high for medical products.

Market Opportunities: Increasing investment and funding

An aging population has created demand for alternative treatments for pain, epilepsy, and other conditions cannabis may help. Public opinion is also becoming more favorable towards legalization as research demonstrates medical benefits. As laws change and scientific evidence grows, the market size is projected to dramatically increase over the next decade. Large investments are pouring in to fund expanded production capacity and research.